Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| QuidelOrtho CorpQDEL · Entity 4986 | SVP, Research & Development | July 28, 2024 | July 30, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
QuidelOrtho Corp
Report date July 28, 2024 · Filed July 30, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 36,357 |
Ending reported balance
After 2024-07-28 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2024-07-28 · Grant · Acquired 1,170 · Balance 36,951 F1: Reflects release of restricted stock units that were previously reported on a Form 4. Row 2 · 2024-07-28 · Tax withholding · Disposed 594 · Balance 36,357 F2: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2024-07-28 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2024-07-28 · Exercise / conversion · Disposed 1,170 · Balance 0 F3: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4: 1,170 shares vested on July 28, 2022; 1,170 shares vested on July 28, 2023; and 1,170 shares vested on July 28, 2024. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects release of restricted stock units that were previously reported on a Form 4.
F2: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units.
F3: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
F4: 1,170 shares vested on July 28, 2022; 1,170 shares vested on July 28, 2023; and 1,170 shares vested on July 28, 2024.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
QUIDEL CORP /DE/
Report date May 27, 2022 · Filed June 01, 2022
Section 16 reporting ended · disclosed 2022-06-01. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2022-05-27 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2022-05-27 · Grant · Acquired 4,376 · Balance 20,932 F1: Reflects release of restricted stock units that were previously reported on a Form 4. Row 2 · 2022-05-27 · Tax withholding · Disposed 2,170 · Balance 18,762 F2: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Row 3 · 2022-05-27 · Disposition to issuer · Disposed 18,762 · Balance 0 F3: Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement will be exchanged for one share of common stock of QuidelOrtho. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2022-05-27 · Exercise / conversion · Disposed 4,376 · Balance 0 F4: Each restricted stock unit represents the right to receive one share of Quidel common stock. F5: Vested in full. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2022-05-27 · Disposition to issuer · Disposed 3,925 · Balance 0 F4: Each restricted stock unit represents the right to receive one share of Quidel common stock. F8: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F9: 3,925 shares will vest on February 4, 2023. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2022-05-27 · Disposition to issuer · Disposed 2,743 · Balance 0 F4: Each restricted stock unit represents the right to receive one share of Quidel common stock. F8: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F10: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2022-05-27 · Disposition to issuer · Disposed 823 · Balance 0 F4: Each restricted stock unit represents the right to receive one share of Quidel common stock. F8: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F10: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2022-05-27 · Disposition to issuer · Disposed 4,268 · Balance 0 F4: Each restricted stock unit represents the right to receive one share of Quidel common stock. F8: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F11: 4,268 shares will vest on February 4, 2023. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2022-05-27 · Disposition to issuer · Disposed 1,962 · Balance 0 F4: Each restricted stock unit represents the right to receive one share of Quidel common stock. F8: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F12: 1,962 shares will vest in equal installments on July 1, 2022 and July 1, 2023. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2022-05-27 · Disposition to issuer · Disposed 2,625 · Balance 0 F4: Each restricted stock unit represents the right to receive one share of Quidel common stock. F8: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F13: 1,312 shares will vest on February 1, 2023; and 1,313 shares will vest on February 1, 2024. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · 2022-05-27 · Disposition to issuer · Disposed 3,510 · Balance 0 F4: Each restricted stock unit represents the right to receive one share of Quidel common stock. F8: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F14: 3,510 shares will vest in equal installments on July 28, 2022, July 28, 2023 and July 28, 2024. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · 2022-05-27 · Disposition to issuer · Disposed 10,642 · Balance 0 F4: Each restricted stock unit represents the right to receive one share of Quidel common stock. F8: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F15: 3,547 shares will vest on each of January 31, 2023 and January 31, 2024; 3,548 shares will vest on January 31, 2025. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 15
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 15 · 2022-05-27 · Disposition to issuer · Disposed 7,256 · Balance 0 F4: Each restricted stock unit represents the right to receive one share of Quidel common stock. F8: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F16: 3,628 shares will vest on January 31, 2024; the remaining 3,628 shares will vest in equal installments on January 31, 2025 and January 31, 2026. |
| Non-Qualified Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $46.41 · Expires 2028-01-16 | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2022-05-27 · Disposition to issuer · Disposed 2,303 · Balance 0 F6: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F5: Vested in full. |
| Non-Qualified Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $59.12 · Expires 2029-02-04 | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2022-05-27 · Disposition to issuer · Disposed 3,924 · Balance 0 F6: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F7: 5,888 shares are vested in full; 1,962 shares will vest on February 4, 2023. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects release of restricted stock units that were previously reported on a Form 4.
F2: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units.
F3: Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement will be exchanged for one share of common stock of QuidelOrtho.
F4: Each restricted stock unit represents the right to receive one share of Quidel common stock.
F5: Vested in full.
F6: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).
F7: 5,888 shares are vested in full; 1,962 shares will vest on February 4, 2023.
F8: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).
F9: 3,925 shares will vest on February 4, 2023.
F10: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule.
F11: 4,268 shares will vest on February 4, 2023.
F12: 1,962 shares will vest in equal installments on July 1, 2022 and July 1, 2023.
F13: 1,312 shares will vest on February 1, 2023; and 1,313 shares will vest on February 1, 2024.
F14: 3,510 shares will vest in equal installments on July 28, 2022, July 28, 2023 and July 28, 2024.
F15: 3,547 shares will vest on each of January 31, 2023 and January 31, 2024; 3,548 shares will vest on January 31, 2025.
F16: 3,628 shares will vest on January 31, 2024; the remaining 3,628 shares will vest in equal installments on January 31, 2025 and January 31, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 28, 2024 Filed Jul 30, 2024 17:34 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units · Derivative | 1,170 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-088060 · ownership.xml · derivative · entry 3 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,170 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 1,170 shares vested on July 28, 2022; 1,170 shares vested on July 28, 2023; and 1,170 shares vested on July 28, 2024. F4 · derivative.expiration_date: 1,170 shares vested on July 28, 2022; 1,170 shares vested on July 28, 2023; and 1,170 shares vested on July 28, 2024. Read SEC document |
| July 28, 2024 Filed Jul 30, 2024 17:34 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Tax withholdingCommon Stock | 594 | $38.91 | $23,112.54 |
DisclosureSEC source: 0000950170-24-088060 · ownership.xml · nonDerivative · entry 2 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,357 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| July 28, 2024 Filed Jul 30, 2024 17:34 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 1,170 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-088060 · ownership.xml · nonDerivative · entry 1 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,951 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| March 28, 2024 Filed Apr 1, 2024 19:58 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units · Derivative | 3,811 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-039664 · ownership.xml · derivative · entry 3 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,622 Underlying: Common Stock · 3,811 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 3,811 shares vested on March 28, 2024; the remaining 7,622 shares will vest in equal installments on March 28, 2025 and March 28, 2026. F4 · derivative.expiration_date: 3,811 shares vested on March 28, 2024; the remaining 7,622 shares will vest in equal installments on March 28, 2025 and March 28, 2026. Read SEC document |
| March 28, 2024 Filed Apr 1, 2024 19:58 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Tax withholdingCommon Stock | 1,801 | $47.94 | $86,339.94 |
DisclosureSEC source: 0000950170-24-039664 · ownership.xml · nonDerivative · entry 2 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,781 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| March 28, 2024 Filed Apr 1, 2024 19:58 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 3,811 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-039664 · ownership.xml · nonDerivative · entry 1 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,582 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 21:46 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantRestricted Stock Units · Derivative | 14,920 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-014153 · ownership.xml · derivative · entry 1 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,920 Underlying: Common Stock · 14,920 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: 9,946 shares will vest in equal installments on February 8, 2025 and February 8, 2026; the remaining 4,974 shares will vest on February 8, 2027. F2 · derivative.expiration_date: 9,946 shares will vest in equal installments on February 8, 2025 and February 8, 2026; the remaining 4,974 shares will vest on February 8, 2027. Read SEC document |
| February 01, 2024 Filed Feb 5, 2024 20:11 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units · Derivative | 1,313 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-011469 · ownership.xml · derivative · entry 3 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,313 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 1,313 shares vested on February 1, 2024. F4 · derivative.expiration_date: 1,313 shares vested on February 1, 2024. Read SEC document |
| February 01, 2024 Filed Feb 5, 2024 20:11 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Tax withholdingCommon Stock | 680 | $69.45 | $47,226.00 |
DisclosureSEC source: 0000950170-24-011469 · ownership.xml · nonDerivative · entry 2 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,771 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| February 01, 2024 Filed Feb 5, 2024 20:11 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 1,313 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-011469 · ownership.xml · nonDerivative · entry 1 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,451 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 20:09 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units · Derivative | 3,547 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-010878 · ownership.xml · derivative · entry 6 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,548 Underlying: Common Stock · 3,547 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F6 · derivative.exercise_date: 3,547 shares vested on January 31, 2024; 3,548 shares will vest on January 31, 2025. F6 · derivative.expiration_date: 3,547 shares vested on January 31, 2024; 3,548 shares will vest on January 31, 2025. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 20:09 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units · Derivative | 3,628 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-010878 · ownership.xml · derivative · entry 5 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,628 Underlying: Common Stock · 3,628 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F5 · derivative.exercise_date: 3,628 shares vested on January 31, 2024; the remining 3,628 shares will vest in equal installments on January 31, 2025 and January 31, 2026. F5 · derivative.expiration_date: 3,628 shares vested on January 31, 2024; the remining 3,628 shares will vest in equal installments on January 31, 2025 and January 31, 2026. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 20:09 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Tax withholdingCommon Stock | 1,806 | $68.51 | $123,729.06 |
DisclosureSEC source: 0000950170-24-010878 · ownership.xml · nonDerivative · entry 4 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,138 F3 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 20:09 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 3,547 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-010878 · ownership.xml · nonDerivative · entry 3 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,944 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 20:09 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Tax withholdingCommon Stock | 1,946 | $68.51 | $133,320.46 |
DisclosureSEC source: 0000950170-24-010878 · ownership.xml · nonDerivative · entry 2 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,397 F3 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 20:09 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 3,628 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-010878 · ownership.xml · nonDerivative · entry 1 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,343 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. F2 · balance_after: The amount of shares beneficially owned following this transaction includes an additional 76 shares due to the Reporting Person's purchase of shares pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| July 28, 2023 Filed Aug 1, 2023 16:05 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units · Derivative | 1,170 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-043942 · doc4.xml · derivative · entry 3 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,170 Underlying: Common Stock · 1,170 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F5 · derivative.exercise_date: 1,170 shares vested on July 28, 2023; 1,170 shares will vest on July 28, 2024. F5 · derivative.expiration_date: 1,170 shares vested on July 28, 2023; 1,170 shares will vest on July 28, 2024. Read SEC document |
| July 28, 2023 Filed Aug 1, 2023 16:05 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Tax withholdingCommon Stock | 549 | $87.12 | $47,828.88 |
DisclosureSEC source: 0001209191-23-043942 · doc4.xml · nonDerivative · entry 2 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,639 F3 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| July 28, 2023 Filed Aug 1, 2023 16:05 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 1,170 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-043942 · doc4.xml · nonDerivative · entry 1 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,188 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. F2 · balance_after: The amount of shares beneficially owned following this transaction include an additional 218 shares due to the Reporting Person's purchase of shares pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| July 01, 2023 Filed Jul 5, 2023 16:05 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units · Derivative | 981 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-040962 · doc4.xml · derivative · entry 3 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 981 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 981 shares vested on July 1, 2023. F4 · derivative.expiration_date: 981 shares vested on July 1, 2023. Read SEC document |
| July 01, 2023 Filed Jul 5, 2023 16:05 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Tax withholdingCommon Stock | 436 | $82.86 | $36,126.96 |
DisclosureSEC source: 0001209191-23-040962 · doc4.xml · nonDerivative · entry 2 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,800 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| July 01, 2023 Filed Jul 5, 2023 16:05 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 981 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-040962 · doc4.xml · nonDerivative · entry 1 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,236 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| March 28, 2023 Filed Mar 30, 2023 19:14 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantRestricted Stock Units · Derivative | 11,433 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-021715 · doc4.xml · derivative · entry 1 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,433 Underlying: Common Stock · 11,433 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: 3,811 shares will vest on the first anniversary date of the grant date, March 28, 2024; 3,811 shares will vest on the second anniversary date of the grant date, March 28, 2025; and 3,811 shares will vest on the third anniversary date of the grant date, March 28, 2026. F2 · derivative.expiration_date: 3,811 shares will vest on the first anniversary date of the grant date, March 28, 2024; 3,811 shares will vest on the second anniversary date of the grant date, March 28, 2025; and 3,811 shares will vest on the third anniversary date of the grant date, March 28, 2026. Read SEC document |
| February 11, 2023 Filed Feb 14, 2023 16:46 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units (Premium) · Derivative | 823 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009170 · doc4.xml · derivative · entry 6 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 823 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and occurred according to the elected deferred schedule. F4 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and occurred according to the elected deferred schedule. Read SEC document |
| February 11, 2023 Filed Feb 14, 2023 16:46 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units (Converted) · Derivative | 2,743 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009170 · doc4.xml · derivative · entry 5 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,743 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and occurred according to the elected deferred schedule. F4 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and occurred according to the elected deferred schedule. Read SEC document |
| February 11, 2023 Filed Feb 14, 2023 16:46 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Tax withholdingCommon Stock | 409 | $86.50 | $35,378.50 |
DisclosureSEC source: 0001209191-23-009170 · doc4.xml · nonDerivative · entry 4 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,255 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| February 11, 2023 Filed Feb 14, 2023 16:46 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 823 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009170 · doc4.xml · nonDerivative · entry 3 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,664 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| February 11, 2023 Filed Feb 14, 2023 16:46 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Tax withholdingCommon Stock | 1,296 | $86.50 | $112,104.00 |
DisclosureSEC source: 0001209191-23-009170 · doc4.xml · nonDerivative · entry 2 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,841 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| February 11, 2023 Filed Feb 14, 2023 16:46 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 2,743 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009170 · doc4.xml · nonDerivative · entry 1 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,137 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| February 04, 2023 Filed Feb 7, 2023 16:15 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units · Derivative | 4,268 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-007501 · doc4.xml · derivative · entry 6 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,268 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F5 · derivative.exercise_date: 4,268 shares vested on February 4, 2023. F5 · derivative.expiration_date: 4,268 shares vested on February 4, 2023. Read SEC document |
| February 04, 2023 Filed Feb 7, 2023 16:15 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units · Derivative | 3,925 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-007501 · doc4.xml · derivative · entry 5 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,925 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 3,925 shares vested on February 4, 2023. F4 · derivative.expiration_date: 3,925 shares vested on February 4, 2023. Read SEC document |
| February 04, 2023 Filed Feb 7, 2023 16:15 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Tax withholdingCommon Stock | 2,117 | $89.70 | $189,894.90 |
DisclosureSEC source: 0001209191-23-007501 · doc4.xml · nonDerivative · entry 4 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,394 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| February 04, 2023 Filed Feb 7, 2023 16:15 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 4,268 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-007501 · doc4.xml · nonDerivative · entry 3 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,511 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| February 04, 2023 Filed Feb 7, 2023 16:15 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Tax withholdingCommon Stock | 1,947 | $89.70 | $174,645.90 |
DisclosureSEC source: 0001209191-23-007501 · doc4.xml · nonDerivative · entry 2 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,243 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| February 04, 2023 Filed Feb 7, 2023 16:15 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 3,925 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-007501 · doc4.xml · nonDerivative · entry 1 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,190 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| February 01, 2023 Filed Feb 2, 2023 17:57 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units · Derivative | 1,312 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-006328 · doc4.xml · derivative · entry 6 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,313 Underlying: Common Stock · 1,312 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F6 · derivative.exercise_date: 1,312 shares vested on February 1, 2023; and 1,313 shares will vest on February 1, 2024. F6 · derivative.expiration_date: 1,312 shares vested on February 1, 2023; and 1,313 shares will vest on February 1, 2024. Read SEC document |
| February 01, 2023 Filed Feb 2, 2023 17:57 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Tax withholdingCommon Stock | 651 | $88.51 | $57,620.01 |
DisclosureSEC source: 0001209191-23-006328 · doc4.xml · nonDerivative · entry 4 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,265 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| February 01, 2023 Filed Feb 2, 2023 17:57 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 1,312 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-006328 · doc4.xml · nonDerivative · entry 3 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,916 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. F3 · balance_after: The amount of securities beneficially owned following this transaction include an additional 51 shares due to the Reporting Person's purchase of shares pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 17:57 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units · Derivative | 3,547 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-006328 · doc4.xml · derivative · entry 5 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,095 Underlying: Common Stock · 3,547 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F5 · derivative.exercise_date: 3,547 shares vested on January 31, 2023; 3,547 shares will vest on January 31, 2024; and 3,548 shares will vest on January 31, 2025. F5 · derivative.expiration_date: 3,547 shares vested on January 31, 2023; 3,547 shares will vest on January 31, 2024; and 3,548 shares will vest on January 31, 2025. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 17:57 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Tax withholdingCommon Stock | 1,840 | $85.61 | $157,522.40 |
DisclosureSEC source: 0001209191-23-006328 · doc4.xml · nonDerivative · entry 2 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,553 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 17:57 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 3,547 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-006328 · doc4.xml · nonDerivative · entry 1 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,393 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| July 28, 2022 Filed Aug 1, 2022 19:16 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units · Derivative | 1,170 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-043761 · doc4.xml · derivative · entry 3 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,340 Underlying: Common Stock · 1,170 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 1,170 shares vested on 7/28/2022 and 2,340 shares will vest in equal installments on July 28, 2023 and July 28, 2024. F4 · derivative.expiration_date: 1,170 shares vested on 7/28/2022 and 2,340 shares will vest in equal installments on July 28, 2023 and July 28, 2024. Read SEC document |
| July 28, 2022 Filed Aug 1, 2022 19:16 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Tax withholdingCommon Stock | 581 | $102.37 | $59,476.97 |
DisclosureSEC source: 0001209191-22-043761 · doc4.xml · nonDerivative · entry 2 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,846 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| July 28, 2022 Filed Aug 1, 2022 19:16 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 1,170 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-043761 · doc4.xml · nonDerivative · entry 1 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,427 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| July 01, 2022 Filed Jul 6, 2022 17:52 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units · Derivative | 981 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-041283 · doc4.xml · derivative · entry 3 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 981 Underlying: Common Stock · 981 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 981 shares vested on July 1, 2022 and 981 shares will vest on July 1, 2023. F4 · derivative.expiration_date: 981 shares vested on July 1, 2022 and 981 shares will vest on July 1, 2023. Read SEC document |
| July 01, 2022 Filed Jul 6, 2022 17:52 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Tax withholdingCommon Stock | 486 | $97.11 | $47,195.46 |
DisclosureSEC source: 0001209191-22-041283 · doc4.xml · nonDerivative · entry 2 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,257 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| July 01, 2022 Filed Jul 6, 2022 17:52 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 981 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-041283 · doc4.xml · nonDerivative · entry 1 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,743 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| May 27, 2022 Filed Jun 1, 2022 16:23 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Disposition to issuerRestricted Stock Units · Derivative | 7,256 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-020398 · doc4.xml · derivative · entry 15 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,256 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Quidel common stock. F8 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F16 · derivative.exercise_date: 3,628 shares will vest on January 31, 2024; the remaining 3,628 shares will vest in equal installments on January 31, 2025 and January 31, 2026. F16 · derivative.expiration_date: 3,628 shares will vest on January 31, 2024; the remaining 3,628 shares will vest in equal installments on January 31, 2025 and January 31, 2026. Read SEC document |
| May 27, 2022 Filed Jun 1, 2022 16:23 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Disposition to issuerRestricted Stock Units · Derivative | 10,642 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-020398 · doc4.xml · derivative · entry 14 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,642 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Quidel common stock. F8 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F15 · derivative.exercise_date: 3,547 shares will vest on each of January 31, 2023 and January 31, 2024; 3,548 shares will vest on January 31, 2025. F15 · derivative.expiration_date: 3,547 shares will vest on each of January 31, 2023 and January 31, 2024; 3,548 shares will vest on January 31, 2025. Read SEC document |
| May 27, 2022 Filed Jun 1, 2022 16:23 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Disposition to issuerRestricted Stock Units · Derivative | 3,510 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-020398 · doc4.xml · derivative · entry 13 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,510 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Quidel common stock. F8 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F14 · derivative.exercise_date: 3,510 shares will vest in equal installments on July 28, 2022, July 28, 2023 and July 28, 2024. F14 · derivative.expiration_date: 3,510 shares will vest in equal installments on July 28, 2022, July 28, 2023 and July 28, 2024. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.